We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How men with HIV are helping others to stay safe and healthy
First published during the 2019 to 2022 Johnson Conservative government
First published during the 2022 to 2024 Sunak Conservative government
Upper Tribunal Administrative Appeals Chamber decision by Judge Markus on 17 January 2020.
How Bonani in Zimbabwe is fighting stigma and discrimination to HIV and AIDS
The Cell and Gene Therapy Catapult has announced the sale of its subsidiary to biotechnology company, Cell Medica.
The CMA has cleared the anticipated purchase of gene therapy company Spark Therapeutics by pharmaceutical company Roche Holdings.
Toremifene (fareston) is associated with a dose-dependent risk of QT prolongation.
How MHRA and OxSonics help cancer drugs go the extra mile.
Following a complex investigation spanning four and a half years, Lee Tomlinson was sentenced yesterday at Hove Trial Centre to 2 years, 10 months imprisonment for his involvement in laundering the proceeds of illegal sales of medicines intended to treat...
Man sentenced for unlawful importation and distribution of medicinal products.
Upper Tribunal Administrative Appeals Chamber decision by Judge Gamble on 9 February 2016.
A 29 year old man was sentenced to prison for selling counterfeit and prescription-only medicines.
First published during the 2016 to 2019 May Conservative government
The Government responds to the ACMD’s further advice on synthetic cannabinoids and advice on methoxetamine and related compounds.
Use has been restricted to 48 hours’ maximum parenteral use under specialist supervision, after a European safety review.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).